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ABSTRACT 
Retinal degenerations are the major cause of incurable blindness characterized by loss 
of retinal photoreceptor cells. Several genes causing these genetic diseases have been 
identified, however the molecular characterization of a high percentage of patients 
affected by retinitis pigmentosa (RP), a common form of retinal degeneration, is still 
unknown. The high genetic heterogeneity of these diseases hampers the 
comprehension of the pathogenetic mechanism causing photoreceptor cell death. 
Therapies are not available yet and for this reason there is a lot of interest in 
understanding the etiology and the pathogenesis of these disorders at a cellular and 
molecular level. Some common features have been identified in different forms of RP. 
Apoptosis was reported to be the final outcome in all RP animal models and patients 
analyzed so far. We recently identified two apoptotic pathways co-activated in 
photoreceptors undergoing cell death in the retinal degeneration (rd1) mouse model of 
autosomal recessive RP. Our studies opened new perspectives together with many 
questions that require deeper analyses in order to take advantage of this knowledge 
and develop new therapeutic approaches. We believe that minimizing cell demise may 
represent a promising curing strategy that needs to be exploited for retinal 
degeneration.  
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APOPTOSIS IN RETINAL DEGENERATION 
Due to the specialized nature of the eye, a non life-essential organ, mutations in retina 
specific genes are not lethal and can cause very specific and disabling forms of visual 
loss. Retinitis pigmentosa (RP), a type of retinal degeneration, represents one of the 
most prevalent causes of visual handicap and is characterized by loss of photoreceptor 
cells and invasion of the retina by the retinal pigment epithelium. As rod photoreceptors 
die, cone viability is also compromised and the disease proceeds toward reduction of 
peripheral field with tunnel vision and finally loss of sight. It is a progressive disease 
causing complete blindness in later life. RP is a genetically heterogeneous disease and, 
up to now, over 50 genes have been identified (http://www.sph.uth.tmc.edu/Retnet/). 
There is a great functional diversity in the types of genes that have been implicated in 
RP and they can be eye specific (e.g. visual transduction cascade, structural proteins, 
retinoid cycle, outer segment renewal, transcription factors) or widely expressed (e.g. 
splicing factors, nucleotide metabolism) 1. Due to genetic and functional diversity of the 
involved proteins, the molecular mechanisms underlying the different forms of RP are 
still not well understood. In all the types of RP analyzed so far apoptosis was reported to 
be the final and common cause of photoreceptor degeneration but the apoptotic 
pathway engaged in the process was not defined until recently. Interestingly, the 
involvement of executioner caspases has been quite controversial. Activation of 
caspase-3 was detected in transgenic rats with a mutation in the Rhodopsin gene 2. 
Nonetheless, several data on different models of the disease indicate a caspase-
independent mechanism 3-5. Moreover the impact of caspase- 3 was evaluated in 
caspase-3-deficient mice. Although ablation of caspase-3 provided transient 
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photoreceptor protection, rod demise proceeded, suggesting that caspase-3 may be 
involved but is not critical in mediating retinal degeneration in vivo 6. 
 
APOPTOSIS IS INITIATED BY CALPAINS IN PHOTORECEPTOR CELLS 
Accumulating evidences imply that mitochondria and the endoplasmic reticulum (ER) 
are major points of integration of pro-apoptotic intrinsic signaling and, in some of these 
cases, caspase inhibition does not prevent apoptosis. Notably the cell death pathways 
elicited by ER stress and following calcium overload differ from classical caspase 
mediated apoptosis and engage calpains 7. Calpains are cysteine proteases 
synthesized as inactive pro-enzymes and activated by increase of intracellular calcium 
levels that stimulate autoprocessing. Calpains are present in the cell as heterodimers, 
composed of an 80 kDa catalytic subunit and a 28 kDa regulatory subunit. In the ER the 
heterodimer is associated with an endogenous calpain inhibitor called calpastatin 
(Figure 1). Activation of calpains requires calpastatin dissociation and then translocation 
to the cytosolic side of the ER 8. The active protease originates by autolytic cleavage of 
the 80 kDa catalytic subunit after Ca2+ stimulated dissociation from the 28 kDa subunit. 
Calpain I and II (micro- and milli-calpain) are expressed in the retina 9 and are activated 
by micromolar and millimolar calcium concentrations respectively. Activation of calpain 
and cathepsin D has been associated to cell death in RP 10-12. In addition, a correlation 
between cell demise and downregulation of calpastatin at the mRNA and protein level 
has been reported in degenerating photoreceptors 11. Calpains do not directly cause 
chromatin condensation but they are proteases activating apoptotic factors, such as 
caspase-12 and AIF. In vivo and in vitro studies showed that AIF and caspase-12 are 
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co-activated and co-localized with fragmented chromatin in apoptotic photoreceptors 12. 
Caspase-12 is a murine caspase belonging to the inflammatory caspase subgroup 
including caspase-1, -4, -5 and -11 localized to the cytoplasmic side of the ER 13. 
Caspase-12 can be activated by cleavage by calpain II following elevation of 
intracellular calcium. The cleaved active form of caspase-12 participates to the 
apoptotic event by translocation to the nucleus or possibly through other caspases 14, 15 
(Figure 1). Apoptosis-inducing factor (AIF) is a flavoprotein localized in the 
mitochondrial intermembrane space. Upon proper apoptotic stimuli AIF exits the 
mitochondrion and directly translocate to the nucleus. Cleavage and release of AIF from 
mitochondria is regulated by calpain I and can occur without cytochrome c release 16. In 
several neuronal degeneration models, including retinal degeneration, translocation of 
AIF to the nucleus was observed prior to the mitochondrial release of cytochrome c 12, 
17, 18. The activated form of AIF translocates to the nucleus participating to DNA 
fragmentation that culminates in cell death (Figure 1).  
The rd1 mouse model of recessive RP has elevated levels of cGMP 19, 20 and this 
results in elevated intracellular calcium 10, 12. This is explained by lack of PDE activity 
controlling cGMP concentration in photoreceptor cells and therefore calcium influx 
through cGMP-gated channels (CNGA, figure 1). Based on these and other data we 
reasoned that increase of intracellular calcium concentration and concomitant down-
regulation of calpastatin 11 may activate calpains and, subsequently, caspase 
independent death pathways. We showed that increase of intracellular calcium and 
activation of calpains are the first events observed in rd1 dying photoreceptors. 
Activation of calpains is followed by translocation of AIF and caspase-12 to the nucleus 
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and chromatin fragmentation. In vitro treatment of rd1 mutant photoreceptors with a 
calcium channel blocker prevented intracellular calcium increase and all the following 
events. This result confirmed the direct link between intracellular increase of calcium 
ions, activation of calpains and apoptosis initiation in mutant photoreceptor cells 12. 
 
APOPTOSIS IN DIFFERENT FORMS OF RETINITIS PIGMENTOSA  
One of the main questions that now need to be addressed is whether different genetic 
lesions trigger the same apoptotic mechanism. This issue will be fundamental for curing 
this genetically heterogeneous but phenotypically similar group of diseases.  
Mutations in the Rhodopsin (RHO) gene underlie 25% of dominant RP and, for that 
reason, are extensively studied. Mutant RHO has been suggested to accumulate in the 
ER and to form aggresomes 21, 22.  Demonstration of ER stress as a consequence to 
mutations in RHO has not been provided in vertebrates so far, nonetheless is most 
likely. In fact, activation of an ER stress response following expression of mutant RHO 
has been recently reported in Drosophila 23. We have shown in fibroblast cells that co-
activation of AIF and caspase-12 occurs as a response to changes in intracellular 
calcium concentrations as well as to protein misfolding 7. We therefore expect these 
same pathways to be activated when mutant RHO aggregates in the ER. We also 
reported that the relative contribution of the two apoptotic factors appears to be 
distinctive during the different stressful events. AIF has a predominant role in response 
to calcium increase as also observed in rd1 mutant photoreceptors. In fact 
downregulation of AIF expression in rd1 photoreceptors completely blocked apoptosis. 
Conversely, decrease of caspase-12 mRNA and protein had only marginal effects in 
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dying rods 12. On the other hand, caspase-12 appeared to play the key function after 
protein accumulation in the ER of fibroblast cells 7. Taking into account all these data, 
we expect co-activation of AIF and caspase-12 in dominant forms of RP caused by toxic 
effects of an aberrant protein such as mutant RHO (Figure 1). We also suppose that, 
differently from what we have shown in rd1 rods, down-regulation of caspase-12 but not 
AIF will provide the best approach to reduce apoptosis caused by RHO mutation.  
A remarkable finding of these studies was the identification of calpains as common 
proteases that act upstream to AIF and to caspase-12 and are activated in response to 
calcium increase and protein misfolding stresses 7. This was also true for the RP 
affected retina. In fact, inhibition of calpain activity prevented in vivo activation of AIF 
and caspase-12 and consequently apoptosis in the rd1 degenerating retina 12. Similarly, 
we also expect that by using inhibitors of retina expressed calpains we can delay or 
stop apoptosis caused by RHO mutations. These results have important implications for 
development of therapeutic strategies, yet further studies are needed to translate these 
preliminary results in effective treatments.  The first issue regards the type of molecules 
and delivery procedures used to block calpain activity in our study. The aldehydes that 
have been intraocularly injected in the mutant mouse and used to down-regulate calpain 
activity are non-specific cysteinyl protease inhibitors and are also effective against the 
proteasome. For this reason, our treatment blocked calpains but possibly also other 
proteases. Secondly, the inhibitors are small molecules that have the advantage to be 
cell-permeable, yet they quickly undergo clearance. Thus, in order to define their long 
time efficacy, repetitive injections should be applied with the risk of retinal damage.  
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Some preliminary study undertaken with other molecules targeting calpains confirmed 
that calpains are key regulators of apoptosis in RP, nevertheless development of long-
lasting application procedures of specific calpain inhibitors will be necessary to develop 
proper therapies for RP patients.  
 
CASPASE INVOLVEMENT IN RETINITIS PIGMENTOSA 
The participation of executioner caspases (i.e. caspase-3, caspase-6 and caspase-7) to 
the activation of programmed cell death in photoreceptors cannot be completely 
excluded. In vivo studies showed that, although rods eventually died in the absence of 
caspase-3, lack of this executioner caspase provided transient photoreceptor protection 
6. We also evaluated the contribution of executioner caspases to photoreceptor 
apoptosis in the rd1 mouse model. We observed that treatment with the pancaspase 
inhibitor zVAD.fmk did not abolish apoptosis but reduced the number of apoptotic cells 
12. The 20% reduction of cells undergoing apoptosis in the presence of zVAD.fmk can 
be explained by a partial contribution of executioner caspases. How can executioner 
caspases be activated in this system? As previously mentioned, AIF plays the key role 
in the activation of apoptosis in rd1 photoreceptors while down-regulation of caspase-12 
does not abolish apoptosis. Nevertheless, caspase-12 probably holds a reinforcing 
effect because apoptosis is reduced in the absence of caspase-12. It is known that 
caspase-12 acts directly by translocation to the nucleus but can also activate 
executioner caspases. We can envisage the scenario in which the boosting effect of 
caspase-12 is partially mediated by executioner caspases and therefore impaired in the 
presence of pancaspase inhibitors or siRNA targeting caspase-12.  
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An alternative explanation for the reduction of apoptotic cells in the presence of 
pancaspase inhibitor derives from the specificity of zVAD.fmk. High doses of zVAD.fmk, 
like those applied in our studies, can also affect calpain activity 24. If so, a reduced 
calpain protease activity will also influence apoptosis and our results can be justified 
simply by calpain activation and rule out involvement of executioner caspases. Hence, 
we cannot exclude that the apoptotic process in the RP retina engages also executioner 
caspases, nevertheless activated forms of caspase-3 have not been revealed by 
immunohistochemistry or immunoblotting so far. 
 
NON-CELL AUTONOMOUS EFFECTS ON CONE VIABILITY 
RP usually begins with night blindness and decreased peripheral vision due to loss of 
rod photoreceptors. The most devastating effect comes with subsequent degeneration 
of cones, which causes loss of color and high acuity vision, ending in total blindness. 
Rod photoreceptors death is therefore followed by reduction of cone viability and it is 
unclear whether this is due to loss of trophic factors or to activation of toxic molecules or 
to both. The fact that cones die in the retina of patients with mutations in rod specific 
genes suggests the presence of a non-cell autonomous mechanism of death that is also 
demonstrated by degeneration of genetically normal photoreceptors adjacent to rods 
that express the mutant protein in chimera mice 25. It is not known whether the same or 
different mechanisms mediate rod and cone degeneration. To address this question we 
counted the number of apoptotic cells in which AIF and caspase-12 were activated 
inside the nucleus. At all the different time points analyzed during retinal degeneration 
we always failed to detect activation of these two apoptosis effectors in 20% of dying 
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cells. We suggested that in situ detection of AIF and caspase-12 fails to detect low 
amounts of these factors in some apoptotic nuclei, but this issue has not been solved 
yet. What is the identity of these cells? Are these cells undergoing apoptosis through a 
different mechanism? It is possible that some photoreceptors, such as cones, die 
through an alternative apoptotic pathway as a consequence of death of neighbouring 
cells. On the contrary, the idea that different mutant rod photoreceptors activate 
different apoptotic pathways in response to the same genetic insult appears unlikely. 
Specific studies aimed at the cellular identification of these dying cells are required to 
define whether the degenerating retina activate several apoptotic mechanisms that 
need to be specifically targeted in order to effectively block or at least delay cell demise 
in this disabling disease.  
 
PERSPECTIVES AND CONCLUSIONS 
As previously discussed, now that the apoptotic pathways have been partially 
unraveled, we need to define whether these same molecular mechanisms are activated 
during cell demise in RP caused by different genetic lesions. In fact, a limiting aspect in 
designing a cure for RP is the still inadequate molecular diagnosis for RP patients and 
the high percentage of isolated instances, occurring in about 40% of RP cases. General 
and common factors activated by mutations of different genes can be the keystone to 
the cure. We started with the identification of calpains that are engaged by high calcium 
and ER stress and are probably upstream to both AIF and caspase-12 activation. 
Specific experiments aimed at defining whether calpains are really activating all the 
downstream catastrophic events leading to cell death or whether they cooperate with 
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other proteases are fundamental to plan effective approaches to stop cell death during 
retinal degeneration. This is an essential issue important to define whether apoptosis 
should be exploited as a therapeutic target for this genetically heterogeneous disease.  
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Figure 1. Interaction between AIF and caspase-12 apoptotic pathways. 
Increase of intracellular Ca2+ levels upon opening of CNGA (cyclic nucleotide gated 
channel alpha) channel activates calpain proteases. Activated calpains act on 
mitochondrial AIF and ER caspase-12. Cleaved AIF and cleaved caspase-12 
translocate to the nucleus and are involved in chromatin fragmentation. siRNA data 
showed that downregulation of caspase-12 in rd1 mutant photoreceptors does not block 
cell death and AIF activation but reduces the number of cells with nuclear AIF and 
undergoing apoptosis. This suggested that caspase-12 has a reinforcing effect shown 
here as dashed arrows and a question mark. The question mark refers to the lack of 
information on the molecular mechanisms involved in the cross-talk between AIF and 
caspase-12: it is still unclear whether these effects are direct or indirect.  
Protein misfolding in the ER causes increased Ca2+ (arrow inside the ER) that can 
activate calpains and then AIF and caspase-12.  
 

